Young women often delay looking into breast symptoms, research finds
Young women who find a lump or other potential signs of breast cancer often delay for weeks before finally seeing a doctor, a new study shows.
Apr 12, 2024
0
0
Young women who find a lump or other potential signs of breast cancer often delay for weeks before finally seeing a doctor, a new study shows.
Apr 12, 2024
0
0
Re-perfusing the lungs of an organ donor with a technique called normothermic regional perfusion (TA-NRP) after the heart has irreversibly stopped beating could potentially increase the number of patients receiving lung transplants, ...
Apr 12, 2024
0
0
While debating the pros and cons of robotically assisted lung transplantation, Albert Jauregui, MD, Ph.D. told attendees at the Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation ...
Apr 11, 2024
0
0
Speaking today at the Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) in Prague, Muhammad Mohiuddin, MBBS, said xenotransplantation, hailed as the future of organ ...
Apr 10, 2024
0
0
The same technology that enables a bullet train to travel at speeds up to 200 mph without touching its rails now keeps a failing heart pumping—and in the near future, it will do so via a wireless power connection. Mandeep ...
Apr 10, 2024
1
10
For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.
Apr 9, 2024
0
2
As part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Medicine's Abramson Cancer Center (ACC) Community Outreach and Engagement team developed a culturally sensitive educational video ...
Apr 9, 2024
0
0
The first-in-class PARP1-selective inhibitor saruparib demonstrated encouraging early efficacy and a favorable safety profile in patients with homologous recombination repair (HRR)-deficient breast cancers, according to results ...
Apr 8, 2024
0
0
New research questions the effectiveness of the U.S. Food and Drug Administration's accelerated drug approval program after finding that many cancer drugs remain unproven five years later.
Apr 8, 2024
0
2
Combining the KRAS G12C inhibitor adagrasib with the anti-EGFR antibody cetuximab demonstrated promising anti-tumor effects in patients with KRAS G12C-mutated metastatic colorectal cancer (CRC), according to pooled results ...
Apr 8, 2024
0
2